Gang Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gang Wu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ning Zhuo
Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China
4 shared publications Gang Wang
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China
3 shared publications- Gang Wang
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China
2 shared publications Ning Zhuo
Department of Nephrology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China
2 shared publications- Dongxu Zhang
Department of Urology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong, China
1 shared publication - Gang Wang
Department of Rheumatology and Immunology, The Second Affiliated Hospital of Soochow University, Suzhou, China
1 shared publication
Latest Publications
- 4 March 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (8) , 2803-2804
Blood-urea-nitrogen-to-serum-albumin ratio predicts contrast-induced nephropathy in coronary heart disease
- 4 March 2024
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (8) , 2803-2804
Blood-urea-nitrogen-to-serum-albumin ratio predicts contrast-induced nephropathy in coronary heart disease
- Open Access
- 24 January 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (1) , 2307957
Letter to the editor regarding ‘Correlation between neutrophil-to-lymphocyte ratio and contrast-induced acute kidney injury and the establishment of machine-learning-based predictive models’
- 24 January 2024
- Published by Taylor & Francis in Renal Failure
- Vol. 46 (1) , 2307957
Open AccessLetter to the editor regarding ‘Correlation between neutrophil-to-lymphocyte ratio and contrast-induced acute kidney injury and the establishment of machine-learning-based predictive models’
- Open Access
- 1 December 2023
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (3) , 323
The Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis
We read with interest the recent retrospective cohort study by Singer and colleagues on the incidence of herpes zoster (HZ) in patients with rheumatoid arthritis (RA) in the United States.1 After analyzing age and treatment regimens in both cohorts, the authors concluded that the incidence of HZ was increased in patients with RA.1
- 1 December 2023
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 51 (3) , 323
Open AccessThe Incidence of Herpes Zoster Is Increased in the Population of Patients With Rheumatoid Arthritis
We read with interest the recent retrospective cohort study by Singer and colleagues on the incidence of herpes zoster (HZ) in patients with rheumatoid arthritis (RA) in the United States.1 After analyzing age and treatment regimens in both cohorts, the authors concluded that the incidence of HZ was increased in patients with RA.1
- 3 November 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (5) , 1775-1776
Neutrophil-to-lymphocyte ratio is an independent risk factor for proteinuria non-remission in idiopathic membranous nephropathy
- 3 November 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (5) , 1775-1776
Neutrophil-to-lymphocyte ratio is an independent risk factor for proteinuria non-remission in idiopathic membranous nephropathy
- 2 October 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (4) , 1509-1510
Comment on “Association of statin use after renal replacement therapy with mortality in patients with dialysis-requiring acute kidney injury”
- 2 October 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (4) , 1509-1510
Comment on “Association of statin use after renal replacement therapy with mortality in patients with dialysis-requiring acute kidney injury”
- 9 September 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (3) , 1203-1204
Comment on "Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross‑sectional analysis of PEAKING study"
- 9 September 2023
- Published by Springer Nature in International Urology and Nephrology
- Vol. 56 (3) , 1203-1204
Comment on "Prevalence and associated factors of frailty in patients with chronic kidney disease: a cross‑sectional analysis of PEAKING study"
- Open Access
- 23 September 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Systematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy
Background and objective: Radical cystectomy has been characterized as the most difficult operation in urology because of the complex surgical procedures and postoperative complications. Enhanced recovery after surgery (ERAS), which reduces the incidence of perioperative complications, has been widely used in clinical surgery. Herein, we performed a meta-analysis to evaluate the efficacy and safety of ERAS vs. conventional recovery after surgery (CRAS) on perioperative outcomes of radical cystectomy. Methods: We performed a systematic search of randomized controlled trials (RCTs) in the following databases: Medline, Embase, and the Cochrane Controlled Trials Register, based on the PICOS strategy. The reference lists of the retrieved studies were further surveyed for relevant publications. Results: Our search yielded seven RCTs containing 813 patients. The ERAS group was found to have better performance in the following parameters: length of hospital stay [mean difference (MD) = −1.12, 95% confidence interval (CI): −1.80 to −0.45, P = 0.001], time to first flatus (MD = −0.70, 95% CI: −0.98 to 0.41, P < 0.00001), and time to regular diet (MD = −0.12, 95% CI: −1.76 to −0.28, P = 0.007). However, there were no significant differences between the two groups in major complications [odds ratio (OR) = 0.91, 95% CI: 0.63 to 1.34, P = 0.64], readmission (OR = 1.15, 95% CI: 0.65 to 2.01, P = 0.63), ileus (OR = 0.75, 95% CI: 0.44 to 1.28, P = 0.29), wound infection (OR = 0.56, 95% CI: 0.31 to 1.01, P = 0.05), mortality (OR = 0.69, 95% CI: 0.24 to 1.99, P = 0.49), or time to first bowel movement (MD = −0.55, 95% CI: −1.62 to 0.53, P = 0.32). Conclusion: ERAS reduced the length of hospital stay, time to first flatus, and time to regular diet after cystectomy. Compared to CRAS protocols, ERAS protocols do not increase the risk of adverse events.
- 23 September 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Open AccessSystematic Review and Meta-Analysis of the Efficacy and Safety of Enhanced Recovery After Surgery vs. Conventional Recovery After Surgery on Perioperative Outcomes of Radical Cystectomy
Background and objective: Radical cystectomy has been characterized as the most difficult operation in urology because of the complex surgical procedures and postoperative complications. Enhanced recovery after surgery (ERAS), which reduces the incidence of perioperative complications, has been widely used in clinical surgery. Herein, we performed a meta-analysis to evaluate the efficacy and safety of ERAS vs. conventional recovery after surgery (CRAS) on perioperative outcomes of radical cystectomy. Methods: We performed a systematic search of randomized controlled trials (RCTs) in the following databases: Medline, Embase, and the Cochrane Controlled Trials Register, based on the PICOS strategy. The reference lists of the retrieved studies were further surveyed for relevant publications. Results: Our search yielded seven RCTs containing 813 patients. The ERAS group was found to have better performance in the following parameters: length of hospital stay [mean difference (MD) = −1.12, 95% confidence interval (CI): −1.80 to −0.45, P = 0.001], time to first flatus (MD = −0.70, 95% CI: −0.98 to 0.41, P < 0.00001), and time to regular diet (MD = −0.12, 95% CI: −1.76 to −0.28, P = 0.007). However, there were no significant differences between the two groups in major complications [odds ratio (OR) = 0.91, 95% CI: 0.63 to 1.34, P = 0.64], readmission (OR = 1.15, 95% CI: 0.65 to 2.01, P = 0.63), ileus (OR = 0.75, 95% CI: 0.44 to 1.28, P = 0.29), wound infection (OR = 0.56, 95% CI: 0.31 to 1.01, P = 0.05), mortality (OR = 0.69, 95% CI: 0.24 to 1.99, P = 0.49), or time to first bowel movement (MD = −0.55, 95% CI: −1.62 to 0.53, P = 0.32). Conclusion: ERAS reduced the length of hospital stay, time to first flatus, and time to regular diet after cystectomy. Compared to CRAS protocols, ERAS protocols do not increase the risk of adverse events.